INS and Hyperglycemia: Hybrid closed-loop (HCL) technology integrates a CGM with an insulin pump and an algorithm to automatically adjust basal insulin in response to sensor glucose changes and predictively adjust insulin delivery to minimize hypoglycemia and hyperglycemia.